{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T21:13:45Z","timestamp":1771881225174,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.jpeds.2006.01.035","type":"journal-article","created":{"date-parts":[[2006,6,12]],"date-time":"2006-06-12T16:47:11Z","timestamp":1150130831000},"page":"831-834","source":"Crossref","is-referenced-by-count":54,"title":["Severe liver injury after initiating therapy with atomoxetine in two children"],"prefix":"10.1016","volume":"148","author":[{"given":"Joel R.","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip R.","family":"Faught","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naga P.","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean P.","family":"Molleston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2006.01.035_bib1","unstructured":"US Food and Drug Administration. Available at http:\/\/www.fda.gov\/medwatch\/SAFETY\/2004\/Strattera_PI.pdf. Accessed March 2005."},{"key":"10.1016\/j.jpeds.2006.01.035_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/dmd.30.3.319","article-title":"Identification of the human Cytochromes P450 responsible for atomoxetine metabolism","volume":"30","author":"Ring","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jpeds.2006.01.035_bib3","doi-asserted-by":"crossref","unstructured":"Guengerich FP. Human cytochrome P450 enzymes. In Ortix de Montellano PR, ed. Cytochrome P450: Structure, Mechanism and Biochemistry. 2nd ed. New York: Plenum Press:473\u2013535.","DOI":"10.1007\/978-1-4757-2391-5_14"},{"key":"10.1016\/j.jpeds.2006.01.035_bib4","unstructured":"Westphal JF, Brogard JM. Antibacterials and antifungal agents. In Kaplowitx N, DeLeve LD, eds. Drug Induced Liver Disease. 1st ed. New York: Marcel Dekker, Inc.:471\u2013504."},{"key":"10.1016\/j.jpeds.2006.01.035_bib5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2165\/00003088-200544060-00002","article-title":"Clinical pharmacokinetics of atomoxetine","volume":"44","author":"Sauer","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpeds.2006.01.035_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1089-3261(05)70097-0","article-title":"Drug-induced liver disease","volume":"4","author":"Zimmerman","year":"2000","journal-title":"Clin Liver Diseases"},{"key":"10.1016\/j.jpeds.2006.01.035_bib7","unstructured":"US Food and Drug Administration. Available at http:\/\/www.fda.gov\/cder\/foi\/label\/2002\/214 11_strattera_lbl.pdf. Accessed June 2004."},{"key":"10.1016\/j.jpeds.2006.01.035_bib8","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reaction to drugs: a novel method based on the conclusions of international consensus meetings: application to drug induced liver injury","volume":"46","author":"Dan","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jpeds.2006.01.035_bib9","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","article-title":"Causality assessment of adverse reactions to drugs, II: an original model for validation of drug causality assessment methods: case reports with positive rechallenge","volume":"46","author":"Benichou","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jpeds.2006.01.035_bib10","first-page":"A171","article-title":"Autoimmune hepatitis induced by statins","volume":"128","author":"Siddiqui","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jpeds.2006.01.035_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1089-3261(03)00021-7","article-title":"Hepatotoxicity of antibiotics and anti-fungals","volume":"7","author":"Thiim","year":"2003","journal-title":"Clin Liver Disease"},{"key":"10.1016\/j.jpeds.2006.01.035_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1389200043335531","article-title":"Cytochrome P-450 and liver disease","volume":"5","author":"Villeneuve","year":"2004","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.jpeds.2006.01.035_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/0891693021000069556","article-title":"A major CYP2D6 autoepitope in autoimmune Hepatitis type 2 and chronic hepatitis C","volume":"35","author":"Sugimura","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jpeds.2006.01.035_bib14","first-page":"331","article-title":"Microsomal antibodies in active chronic hepatitis and other disorders","volume":"15","author":"Rizzetto","year":"1973","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jpeds.2006.01.035_bib15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1084\/jem.161.5.1231","article-title":"Anti-liver kidney microsomal antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum","volume":"161","author":"Alvarez","year":"1985","journal-title":"J Exp Med"},{"key":"10.1016\/j.jpeds.2006.01.035_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1089-3261(02)00025-9","article-title":"Immune-mediated drug-induced liver disease","volume":"6","author":"Liu","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jpeds.2006.01.035_bib17","unstructured":"US Food and Drug Administration. Available at http:\/\/www.fda.gov\/bbs\/topics\/answers\/2004\/ANSO1335.html. Accessed March 2005."},{"key":"10.1016\/j.jpeds.2006.01.035_bib18","unstructured":"Eli Lilly. Available at http:\/\/www.lillytrials.com\/results_files\/Strattera_summary_4642.pdf. Accessed February 2005."},{"key":"10.1016\/j.jpeds.2006.01.035_bib19","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/00004583-200106000-00006","article-title":"Pemoline hepatotoxicity and post-marketing surveillance","volume":"40","author":"Safer","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002234760600014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002234760600014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T09:23:29Z","timestamp":1555665809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002234760600014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S002234760600014X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2006.01.035","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}